CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mannkind Corporation Company Snapshot
Mannkind Corporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mannkind with three other companies in this sector in the United States: ProQR Therapeutics NV (2012 sales of $29,686.33 of which 100% was Pharmaceutical), Boston Therapeutics Inc ($42,254.00 of which 100% was Sugardown TM), and Generex Biotechnology Corporation ($28,651.00 of which 100% was Drug Delivery Technology).

Sales Analysis.
   
   
 
  Stock Performance Chart for Mannkind Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): .69
(Figures in U.S. Dollars)
1 Week 2.7%   13 Weeks 11.4%  
4 Weeks 36.4%   52 Weeks -26.2%  
 
Mannkind Corporation Key Data:
  Ticker: MNKD Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2012 Sales 35,000
(Year Ending Jan 2013).
Employees: 192
  Currency: U.S. Dollars Market Cap: 327,831,668
  Fiscal Yr Ends: December Shares Outstanding: 478,376,869
  Share Type: Common Closely Held Shares: 155,610,485
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.